Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

HVO

Hvivo (HVO)

Hvivo Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:HVO
DateHeureSourceTitreSymboleSociété
29/04/202112h39UK RegulatoryOpen Orphan PLC Result of General MeetingLSE:HVOHvivo Plc
13/04/202108h00UK RegulatoryOpen Orphan PLC Potential demerger of certain non-core assetsLSE:HVOHvivo Plc
09/04/202111h33Alliance NewsAlliance NewsOpen Orphan launches new data platform to combat infectious diseasesLSE:HVOHvivo Plc
09/04/202108h00RNS Non-RegulatoryOpen Orphan PLC Launch of Disease in Motion platformLSE:HVOHvivo Plc
31/03/202108h00UK RegulatoryOpen Orphan PLC Holding(s) in CompanyLSE:HVOHvivo Plc
26/03/202115h36Alliance NewsAlliance NewsTRADING UPDATES: Renew to buy J Browne; Idox in good start to yearLSE:HVOHvivo Plc
26/03/202108h00UK RegulatoryOpen Orphan PLC GBP7.5m Human Challenge Study ContractLSE:HVOHvivo Plc
25/03/202118h14Alliance NewsAlliance NewsTRADING UPDATES: SpaceandPeople swings to loss in 2020 amid virusLSE:HVOHvivo Plc
25/03/202108h00UK RegulatoryOpen Orphan PLC COVID-19 Human Challenge Programme updateLSE:HVOHvivo Plc
11/03/202108h00RNS Non-RegulatoryOpen Orphan PLC Journal for Clinical Studies article publicationLSE:HVOHvivo Plc
09/03/202115h31Alliance NewsAlliance NewsIN BRIEF: Open Orphan wins new contract with Oxford BioTherapeuticsLSE:HVOHvivo Plc
09/03/202108h00UK RegulatoryOpen Orphan PLC New contract win with Oxford BioTherapeuticsLSE:HVOHvivo Plc
17/02/202114h48Alliance NewsAlliance NewsIN BRIEF: Open Orphan Covid Characterisation Study Gets ApprovalLSE:HVOHvivo Plc
17/02/202110h00UK RegulatoryOpen Orphan PLC Ethics approval - COVID-19 Human Challenge StudyLSE:HVOHvivo Plc
03/02/202112h55Alliance NewsAlliance NewsIN BRIEF: Open Orphan Launches New Quarantine Clinic In LondonLSE:HVOHvivo Plc
03/02/202108h05UK RegulatoryOpen Orphan PLC Exercise of Investor Warrants & TVRLSE:HVOHvivo Plc
03/02/202108h00UK RegulatoryOpen Orphan PLC New challenge study quarantine clinicLSE:HVOHvivo Plc
01/02/202112h54Alliance NewsAlliance NewsIN BRIEF: Open Orphan Inks Contract Renewal With Carna BiosciencesLSE:HVOHvivo Plc
01/02/202108h00UK RegulatoryOpen Orphan PLC Contract extension with Carna BiosciencesLSE:HVOHvivo Plc
21/01/202108h00RNS Non-RegulatoryOpen Orphan PLC Article published in Drug Discovery TodayLSE:HVOHvivo Plc
20/01/202122h16Alliance NewsAlliance NewsIN BRIEF: Open Orphan Opens Two New Volunteer Recruitment CentresLSE:HVOHvivo Plc
20/01/202108h00UK RegulatoryOpen Orphan PLC Expansion of volunteer recruitment centresLSE:HVOHvivo Plc
11/01/202112h45Alliance NewsAlliance NewsOpen Orphan Doses First Volunteer In Needle Free Covid Vaccine TrialLSE:HVOHvivo Plc
11/01/202108h00UK RegulatoryOpen Orphan PLC First volunteer dosed in COVID-19 clinical trialLSE:HVOHvivo Plc
06/01/202115h37Alliance NewsAlliance NewsIN BRIEF: Open Orphan Inks Contract Renewal With Top-3 Pharma ClientLSE:HVOHvivo Plc
06/01/202108h00UK RegulatoryOpen Orphan PLC Contract renewal with top-3 pharmaceutical clientLSE:HVOHvivo Plc
31/12/202008h00UK RegulatoryOpen Orphan PLC Rule 19.6(c) ConfirmationLSE:HVOHvivo Plc
23/12/202020h50Alliance NewsAlliance NewsUK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA BoostLSE:HVOHvivo Plc
23/12/202008h00RNS Non-RegulatoryOpen Orphan PLC Successful completion of toxicology studyLSE:HVOHvivo Plc
22/12/202015h26Alliance NewsAlliance NewsIN BRIEF: Open Orphan Pens Contract Extension With Major ClientLSE:HVOHvivo Plc
 Showing the most relevant articles for your search:LSE:HVO